Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Click here to browse AJSM online!

Sign In to gain access to subscriptions and/or personal tools.
Medical Care Research and Review
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Chernew, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chernew, M.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

HMO Use of Diagnostic Tests: A Review of the Evidence

Michael Chernew

University of Midcigan

This article reviews twenty-four studies that compare health maintenance organization (HMO) use ofdiagnostic testing services tofee-for-service(FFS) use. Diagnosticservices contribute to both the high level and the growth of health care costs. This review of a series of studies is important because any single study is commonly limited to a small set of diagnostic tests and generally provides analysis restricted to one, or afew, HMOs. Combining evidence from each of the studies yields thefollowing conclusions. Relative to FFS enrollees, HMO enrollees receive fewer inpatient diagnostic tests. Evidence concerning HMO utilization of outpatient testing relative to FFS plans, though mixed, tends to suggest that HMOs do not perform more ofthese services and may performfewer for patients with chronic illnesses. Quality of care does not appear to suffer in HMOs despite lower testing rates, suggesting HMOs reduce testing in situations in which the incremental value is small.

Medical Care Research and Review, Vol. 52, No. 2, 196-222 (1995)
DOI: 10.1177/107755879505200203


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
Arch OphthalmolHome page
W. Shrank, S. L. Ettner, P. H. Slavin, and H. J. Kaplan
Effect of Physician Reimbursement Methodology on the Rate and Cost of Cataract Surgery
Arch Ophthalmol, December 1, 2005; 123(12): 1733 - 1738.
[Abstract] [Full Text] [PDF]


Home page
Public Finance ReviewHome page
A. C. Goodman and M. Stano
Hmos and Health Externalities: A Local Public Good Perspective
Public Finance Review, May 1, 2000; 28(3): 247 - 269.
[Abstract] [PDF]


Home page
Med Care Res RevHome page
F. J. Hellinger
The Impact of Financial Incentives on Physician Behavior in Managed Care Plans: A Review of the Evidence
Med Care Res Rev, September 1, 1996; 53(3): 294 - 314.
[Abstract] [PDF]